Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ashkon Rahbari"'
Autor:
Cathy Wang, Sean Bujarski, Camilia Soof, Eric Souther, Tahmineh Safaie, Saurabh Patil, Tanya M. Spektor, Ashkon Rahbari, Mingjie Li, Eric Sanchez, James R. Berenson, Scott Jew, Marsiye Emamy-Sadr, Regina A. Swift, Tiffany Chang, Haiming Chen
Publikováno v:
British Journal of Haematology. 192:272-280
Serum B-cell maturation antigen (sBCMA) is a novel biomarker for B-cell malignancies. A normal reference range (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::003cae1a618aedacaa2f20c02ed74bc1
https://doi.org/10.1111/bjh.16752
https://doi.org/10.1111/bjh.16752
Autor:
Ashkon Rahbari, Wungki Park, Victoria M. Villaflor, Lauren Chiec, Bhoomika Sukhadia, Nisha Mohindra, Victor Wang, Garrett M. Frampton, Sangmin Chang, Jeffrey S. Ross, Si Wang, Zachary R. Chalmers, Siraj M. Ali, Jonathan F. Anker, Vaia Florou, Sang Ha Shin, Jeffrey H. Chuang, Pedro Viveiros, Lee Chun Park, Diana Saravia, Gilberto Lopes, Muhammad Mubbashir Sheikh, Young Kwang Chae, Ethan Sokol, Michael Oh
Publikováno v:
Journal of Thoracic Oncology. 14:1807-1817
Introduction Presently, programmed death ligand 1 is the most commonly used biomarker to predict response to immune checkpoint inhibitors (ICIs) in NSCLC. Owing to its several limitations, there is continuous search for more precise and reliable mark
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14b8b8003f7bbed1dee8bc4dd00df5a5
https://doi.org/10.1016/j.jtho.2019.06.016
https://doi.org/10.1016/j.jtho.2019.06.016
Autor:
Marsiye Emamy-Sadr, James R. Berenson, Camilia Soof, Christine Sutanto, Cathy Wang, Tahmineh Safaie, Tanya M. Spektor, Mingjie Li, Haiming Chen, Ashkon Rahbari, Bernard Regidor, Kyle Udd, Sean Bujarski, Ning Xu, Joshua Stern, Eric Souther, Regina A. Swift, Saurabh Patil
Publikováno v:
Targeted oncology. 16(4)
B-cell maturation antigen (BCMA) is expressed on malignant plasma cells from patients with multiple myeloma (MM). These patients have higher levels of serum (s)BCMA than healthy subjects, and levels correlate with disease status. The half-life of sBC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fb21cd90d0da02e3af1bf65995a88e2
https://pubmed.ncbi.nlm.nih.gov/34097243
https://pubmed.ncbi.nlm.nih.gov/34097243
Autor:
Haiming Chen, Tahmineh Safaie, Tanya M. Spektor, Saurabh Patil, Scott Jew, Sean Bujarski, Camilia Soof, Ashkon Rahbari, Eric Souther, Marsiye Emamy-Sadr, Mingjie Li, Cathy Wang, Eric Sanchez, James R. Berenson, Regina A. Swift
Publikováno v:
British journal of haematologyReferences. 192(6)
The serum B-cell maturation antigen (sBCMA) has been identified as a novel serum biomarker for patients with multiple myeloma. However, no study has yet established a reference range for sBCMA levels. Its levels were determined in 196 healthy subject
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0665135e8b23b470686f54596903c89d
https://pubmed.ncbi.nlm.nih.gov/32321191
https://pubmed.ncbi.nlm.nih.gov/32321191
Autor:
Tina Maluso, Regina A. Swift, Jason D. Nosrati, Eric Wirtschafter, Michael Ghermezi, Aleksandra Vidisheva, James R. Berenson, Sean Bujarski, Tanya M. Spektor, Kyle Udd, Zachary Gross, Benjamin Eades, Gary Cecchi, Ashkon Rahbari
Publikováno v:
European Journal of Haematology. 100:621-623
Objective To evaluate the efficacy and safety of elotuzumab and dexamethasone (Ed) for relapsed or refractory multiple myeloma (RRMM) patients. Method This retrospective study evaluated the efficacy and safety of (Ed) treatment for 21 RRMM patients,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f81be2a387df03177357afe657ef252a
https://doi.org/10.1111/ejh.13058
https://doi.org/10.1111/ejh.13058
Autor:
Michael David, James Wang, Ashkon Rahbari, Julia Linesch, Jason D. Nosrati, Laura Z. Rassenti, Thomas J. Kipps, Tanya M. Spektor, Nika M Harutyunyan, Eric Sanchez, James R. Berenson, Kyle Udd, Suzie Vardanyan, Matthew Ghermezi, Eric Wirtschafter, Sean Bujarski, Mingjie Li, Haiming Chen
Publikováno v:
Targeted oncology. 14(5)
Chronic lymphocytic leukemia (CLL) is a malignancy of late B cells. In another late B-cell malignancy (multiple myeloma), levels of solubilized B-cell maturation antigen (sBCMA) are elevated and predict outcomes.We sought to evaluate sBCMA as a possi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e270827140524f9e93af16c1c3d7580d
https://pubmed.ncbi.nlm.nih.gov/31473933
https://pubmed.ncbi.nlm.nih.gov/31473933
Autor:
Joshua Stern, Marsiye Emamy-Sadr, Saurabh Patil, Eric Souther, Tahmineh Safaie, Tanya M. Spektor, Camilia Soof, Cathy Wang, Mingjie Li, Eric Sanchez, James R. Berenson, Sean Bujarski, Ning Xu, Kyle Udd, Regina A. Swift, Ashkon Rahbari, Haiming Chen
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e173-e174
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::704c3e3f0311c42417c4d428341b85a7
https://doi.org/10.1016/j.clml.2019.09.290
https://doi.org/10.1016/j.clml.2019.09.290
Autor:
Ashkon Rahbari, Haiming Chen, Eric Souther, Cathy Wang, Camilia Soof, Eric Sanchez, James R. Berenson, Tiffany Chang, Sean Bujarski, Mingjie Li, Scott Jew, Saurabh Patil, Marsiye Emamy-Sadr, Tahmineh Safaie, Regina A. Swift
Publikováno v:
Blood. 134:4393-4393
Introduction: B-cell maturation antigen (BCMA) is increased in the serum (s) of multiple myeloma (MM) patients (pts). We have previously shown that baseline sBCMA levels predict outcomes for MM pts. The purpose of this study was to determine whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b08d167444b1aeb82470faea13852efc
https://doi.org/10.1182/blood-2019-132013
https://doi.org/10.1182/blood-2019-132013
Autor:
Marsiye Emamy-Sadr, Regina A. Swift, Sean Bujarski, Mingjie Li, Camilia Soof, Joshua Stern, Kyle Udd, Saurabh Patil, Haiming Chen, Ashkon Rahbari, Tanya M. Spektor, Eric Sanchez, James R. Berenson, Tahmineh Safaie, Eric Souther, Ning Xu, Cathy Wang
Publikováno v:
Blood. 134:1786-1786
Introduction: B-cell maturation antigen (BCMA) is a protein that is expressed on malignant plasma cells from patients (pts) with multiple myeloma (MM). Our group has previously shown that MM pts have higher levels of serum (s) BCMA than healthy subje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e25359713202d3c9dc4afb242d995eb
https://doi.org/10.1182/blood-2019-132012
https://doi.org/10.1182/blood-2019-132012
Autor:
Tiffany Chang, Regina A. Swift, Haiming Chen, Tahmineh Safaie, Eric Souther, Ashkon Rahbari, Saurabh Patil, Eric Sanchez, James R. Berenson, Camilia Soof, Scott Jew, Cathy Wang, Marsiye Emamy-Sadr, Sean Bujarski, Mingjie Li
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e174
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90015a1e46cc3108e6c43059f460a30f
https://doi.org/10.1016/j.clml.2019.09.291
https://doi.org/10.1016/j.clml.2019.09.291